Demyelinating Events Following Initiation of Anti-TNF{alpha} Therapy in the British Society for Rheumatology Biologics Registry in Rheumatoid Arthritis
Conclusions
Demyelination following anti-TNF therapy is uncommon. Patients receiving anti-TNFα therapy show a marginally increased SIR; this is lost in sensitivity analyses. Patients concerned about anti–TNFα-associated demyelination can be relatively reassured by these data.
Source: Neurology Neuroimmunology and Neuroinflammation - Category: Neurology Authors: Taylor, T. R. P., Galloway, J., Davies, R., Hyrich, K., Dobson, R. Tags: Autoimmune diseases, All Medical/Systemic disease, All Demyelinating disease (CNS) Article Source Type: research
More News: Arthritis | Autoimmune Disease | Brain | Neurology | Rheumatoid Arthritis | Rheumatology | Study | UK Health